New Results
Nanoviricide’s platform technology based NV-CoV-2 polymer increases the half-life of Remdesivir in vivo
Ashok Chakraborty, Anil Diwan, Vinod Arora, Yogesh Thakur, Vijetha Chiniga, Jay Tatake, Preetam Holkar, Neelam Holkar, Bethany Pond
doi: https://doi.org/10.1101/2021.11.17.468980
Ashok Chakraborty
1Allexcel
Ph.D.Anil Diwan
2Nanoviricides, inc
Ph.D.Vinod Arora
3Allexcel, Inc.
Ph.D.Yogesh Thakur
3Allexcel, Inc.
M.ScVijetha Chiniga
3Allexcel, Inc.
M.Sc.Jay Tatake
4Allexcel, Inc
Ph.D.Preetam Holkar
4Allexcel, Inc
M.S.Neelam Holkar
4Allexcel, Inc
MS.Bethany Pond
4Allexcel, Inc
MS.
Article usage
Posted November 19, 2021.
Nanoviricide’s platform technology based NV-CoV-2 polymer increases the half-life of Remdesivir in vivo
Ashok Chakraborty, Anil Diwan, Vinod Arora, Yogesh Thakur, Vijetha Chiniga, Jay Tatake, Preetam Holkar, Neelam Holkar, Bethany Pond
bioRxiv 2021.11.17.468980; doi: https://doi.org/10.1101/2021.11.17.468980
Nanoviricide’s platform technology based NV-CoV-2 polymer increases the half-life of Remdesivir in vivo
Ashok Chakraborty, Anil Diwan, Vinod Arora, Yogesh Thakur, Vijetha Chiniga, Jay Tatake, Preetam Holkar, Neelam Holkar, Bethany Pond
bioRxiv 2021.11.17.468980; doi: https://doi.org/10.1101/2021.11.17.468980
Subject Area
Subject Areas
- Biochemistry (10770)
- Bioengineering (8030)
- Bioinformatics (27243)
- Biophysics (13955)
- Cancer Biology (11105)
- Cell Biology (16022)
- Clinical Trials (138)
- Developmental Biology (8767)
- Ecology (13262)
- Epidemiology (2067)
- Evolutionary Biology (17337)
- Genetics (11677)
- Genomics (15901)
- Immunology (11010)
- Microbiology (26028)
- Molecular Biology (10624)
- Neuroscience (56439)
- Paleontology (417)
- Pathology (1729)
- Pharmacology and Toxicology (2999)
- Physiology (4538)
- Plant Biology (9614)
- Synthetic Biology (2682)
- Systems Biology (6967)
- Zoology (1508)